BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 16751391)

  • 1. IL-4 receptor alpha is an important modulator of IL-4 and IL-13 receptor binding: implications for the development of therapeutic targets.
    Andrews AL; Holloway JW; Holgate ST; Davies DE
    J Immunol; 2006 Jun; 176(12):7456-61. PubMed ID: 16751391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstitution of a functional human type II IL-4/IL-13 receptor in mouse B cells: demonstration of species specificity.
    Andrews R; Rosa L; Daines M; Khurana Hershey G
    J Immunol; 2001 Feb; 166(3):1716-22. PubMed ID: 11160216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic analysis of the interleukin-13 receptor complex.
    Andrews AL; Holloway JW; Puddicombe SM; Holgate ST; Davies DE
    J Biol Chem; 2002 Nov; 277(48):46073-8. PubMed ID: 12354755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diminished responses to IL-13 by human monocytes differentiated in vitro: role of the IL-13Ralpha1 chain and STAT6.
    Hart PH; Bonder CS; Balogh J; Dickensheets HL; Vazquez N; Davies KV; Finlay-Jones JJ; Donnelly RP
    Eur J Immunol; 1999 Jul; 29(7):2087-97. PubMed ID: 10427971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure, binding, and antagonists in the IL-4/IL-13 receptor system.
    Mueller TD; Zhang JL; Sebald W; Duschl A
    Biochim Biophys Acta; 2002 Nov; 1592(3):237-50. PubMed ID: 12421669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: overexpression of the nonsignaling interleukin-13 receptor alpha2.
    Feng N; Lugli SM; Schnyder B; Gauchat JF; Graber P; Schlagenhauf E; Schnarr B; Wiederkehr-Adam M; Duschl A; Heim MH; Lutz RA; Moser R
    Lab Invest; 1998 May; 78(5):591-602. PubMed ID: 9605184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells.
    Rahaman SO; Sharma P; Harbor PC; Aman MJ; Vogelbaum MA; Haque SJ
    Cancer Res; 2002 Feb; 62(4):1103-9. PubMed ID: 11861389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system.
    LaPorte SL; Juo ZS; Vaclavikova J; Colf LA; Qi X; Heller NM; Keegan AD; Garcia KC
    Cell; 2008 Jan; 132(2):259-72. PubMed ID: 18243101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha.
    Doucet C; Giron-Michel J; Canonica GW; Azzarone B
    Eur J Immunol; 2002 Sep; 32(9):2437-49. PubMed ID: 12207328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4.
    Schnare M; Blum H; Jüttner S; Röllinghoff M; Gessner A
    J Immunol; 1998 Oct; 161(7):3484-92. PubMed ID: 9759868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-gamma, IL-4 and IL-13 modulate responsiveness of human airway smooth muscle cells to IL-13.
    Moynihan BJ; Tolloczko B; El Bassam S; Ferraro P; Michoud MC; Martin JG; Laberge S
    Respir Res; 2008 Dec; 9(1):84. PubMed ID: 19116009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and structure of interleukin 4 receptors in primary meningeal tumors.
    Puri S; Joshi BH; Sarkar C; Mahapatra AK; Hussain E; Sinha S
    Cancer; 2005 May; 103(10):2132-42. PubMed ID: 15830341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain.
    Schnyder B; Lugli S; Feng N; Etter H; Lutz RA; Ryffel B; Sugamura K; Wunderli-Allenspach H; Moser R
    Blood; 1996 May; 87(10):4286-95. PubMed ID: 8639787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of interleukin-13 and interleukin-4 to the interleukin (IL)-4/IL-13 receptor of human synovial fibroblasts.
    Lutz RA; Feng N; Moser R
    J Recept Signal Transduct Res; 1999; 19(1-4):181-90. PubMed ID: 10071757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A modular interface of IL-4 allows for scalable affinity without affecting specificity for the IL-4 receptor.
    Kraich M; Klein M; Patiño E; Harrer H; Nickel J; Sebald W; Mueller TD
    BMC Biol; 2006 Apr; 4():13. PubMed ID: 16640778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncostatin M (OSM) primes IL-13- and IL-4-induced eotaxin responses in fibroblasts: regulation of the type-II IL-4 receptor chains IL-4Ralpha and IL-13Ralpha1.
    Fritz DK; Kerr C; Botelho F; Stampfli M; Richards CD
    Exp Cell Res; 2009 Dec; 315(20):3486-99. PubMed ID: 19799897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of interleukin-13 antagonist (IL-13E13K) in cells expressing various types of IL-4R.
    Kioi M; Kawakami K; Puri RK
    Cell Immunol; 2004 May; 229(1):41-51. PubMed ID: 15331327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Level of expression of IL-13R alpha 2 impacts receptor distribution and IL-13 signaling.
    Daines MO; Tabata Y; Walker BA; Chen W; Warrier MR; Basu S; Hershey GK
    J Immunol; 2006 Jun; 176(12):7495-501. PubMed ID: 16751396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts.
    Doucet C; Brouty-Boyé D; Pottin-Clemenceau C; Jasmin C; Canonica GW; Azzarone B
    Int Immunol; 1998 Oct; 10(10):1421-33. PubMed ID: 9796908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution structure of human IL-13 and implication for receptor binding.
    Moy FJ; Diblasio E; Wilhelm J; Powers R
    J Mol Biol; 2001 Jun; 310(1):219-30. PubMed ID: 11419948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.